Volibo R, Repaglinide/ Voglibose

Repaglinide is used in the treatment of type 2 diabetes mellitus.

Repaglinide works in the treatment of type 2 diabetes by by increasing the amount of insulin produced by the pancreas, which in turn helps in the treatment of type 2 diabetes. Insulin is made naturally in the pancreas which helps control the level of sugar in the blood.If the body does not make enough or makes inefficient insulin this causes increase of blood glucose and diabetes. Thus Repaglinide lowers the blood glucose levels by helping the pancreas produce more Insulin.

Patients who take Repaglinide may suffer from such side effects;

Hypoglycemia (Low blood sugar level),
Abdominal pain,
Diarrhoea,
Sweating,
Nausea,
Dizzyness

Voglibose is used in the treatment of type 2 diabetes.

Voglibose gets activated in the small intestine. Voglibose works to inhibit enzymes which are responsible for the breakdown of complex sugar into simple sugars such as glucose. this then slows the digestion of sugar in the intestines and primarily lowers the post-meal rise in blood sugar levels.

Some of the potential side effects of Voglibose include the symptoms below;

Skin rash,
Flatulence,
Abdominal pain,
Diarrhoea